MedTrace Logo

Effects of Complementary Feeding of Eggs on Infant Development and Growth in Guatemala: The Saqmolo Study

NCT04316221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2026-03-13

No results posted yet for this study

Summary

The specific aims of this study are:

In a randomized controlled trial, the investigators will evaluate the impact of daily egg consumption during the complementary feeding period in addition to the local standard of nutrition care (i.e., intervention group), compared to the local standard of nutrition care alone (i.e., control group) on the following outcomes, in infants that are \~6-month old at baseline:

1. Child development, as measured by global development scores (primary outcome)
2. Growth, as measured by anthropometrics (secondary outcome)
3. Diet quality, as measured by the World Health Organization infant and young child feeding indicators (secondary outcome)

Hypothesis: The investigators hypothesize that daily consumption of eggs during the complementary feeding period, in addition to the local standard of nutrition care, will improve child development, growth, and diet quality compared to the local standard of care alone.

Conditions

  • Growth
  • Development; Delayed

Interventions

DIETARY_SUPPLEMENT

Eggs plus standard of care

Eggs will be secured locally and delivered to families weekly.

OTHER

Standar of care

frequent growth monitoring, general nutrition education, parasite treatment, and multiple micronutrient supplementation.

Sponsors & Collaborators

  • Wuqu' Kawoq, Maya Health Alliance

    collaborator OTHER

  • Think Healthy Group, Inc.

    collaborator NETWORK

  • Academy of Nutrition and Dietetics

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
9 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Guatemala

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316221 on ClinicalTrials.gov